Neurostimulation parameter authentication and expiration system for neurostimulation
Inventors
CALLE, Guillermo Alonso • JOHNSTON, Jacob Aaron
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Methods and apparatuses (e.g., devices and systems) for securely accessing, activating and/or updating vagus nerve stimulators. In particular, described herein are methods and apparatuses for securing providing, verifying and/or executing digital prescriptions for implantable (including implanted) vagus nerve stimulation systems that may be used for treating inflammation. These methods and apparatuses (including software and/or firmware) may be adapted for used with low-energy requirements of the implanted components.
Core Innovation
The invention concerns authorizing communication with an implanted therapy system through digitally signed certificates associated with a clinician and a date and/or time setting. The system verifies the digital signatures using an implant-specific key or a public key maintained in the system, modifies system operation based on the authorized communication, and updates its date and/or time setting.
The implantable therapy system applies electrical stimulation to a nerve and comprises electrodes and processors configured for communication verification and system modification. The disclosure further describes setting electrical stimulation parameters, updating software or firmware, and applying expiration or treatment-count limits that condition dose delivery or prompt notifications.
Claims Coverage
The relevant claims include two independent claims reciting five inventive features directed to a method of authorizing communication with an implanted therapy system and an implantable therapy system for applying electrical stimulation to a nerve.
Verification of digitally signed communication
Claim 1 covers receiving a communication from a clinician verified by a remote server with a digitally signed certificate and a date and/or time setting with a second digitally signed certificate, and verifying both digital signatures using an implant-specific key or a public key.
Modification of system operation and date and/or time setting
Claim 1 covers modifying operation of the implanted therapy system based on the authorized communication and modifying the system's date and/or time setting after verification of the second digital signature.
Implantable nerve-stimulation system
Claim 17 covers an implantable therapy system for applying electrical stimulation to a nerve, comprising one or more electrodes and one or more processors with memory storing instructions to perform communication-verification and system-modification operations.
Operational changes and treatment limits
Dependent claims specify setting electrical stimulation parameters, updating software or firmware, applying expiration or treatment-count limits, issuing notifications, suspending stimulation, and renewing expiration information.
Communication paths
Dependent claims specify receiving communication through the internet and/or a patient's smartphone.
The claims cover a method and an implantable nerve-stimulation system that verify digitally signed clinician communications before modifying system operation and date and/or time settings, along with operational changes, treatment limits, and communication paths.
Stated Advantages
Not explicitly described in patent.
Documented Applications
An implantable therapy system for applying electrical stimulation to a nerve, including authorized remote modification to set stimulation parameters or update software and firmware.
Updating an implanted therapy system's date and/or time setting and renewing expiration information for stimulation parameters through signed communications.
Controlling dose or stimulation delivery based on clock validity, expiration, and treatment-count limits, including suspending stimulation or prompting notifications.
Communication with the implanted therapy system via the internet and/or a patient's smartphone, including interfaces for prescription refill notices, approvals, or required office visits.
Interested in licensing this patent?